Vivet Therapeutics Presents Three Posters on Cerebrotendinous Xanthomatosis Program and Novel AAV Gene Delivery Platform at European Society of Gene and Cell Therapy Annual Congress 2024 ...
The minister also stated that climate change has contributed to the growing burden of certain respiratory illnesses, such as cardiovascular conditions.